Quanome Technologies, Inc. (QNME)
NASDAQ: QNME · Real-Time Price · USD
0.32105
+0.0160 (5.23%)
Aug 25, 2026, 11:22 AM EDT - Market open

Quanome Technologies Financials Overview

Millions USD. Fiscal year is Jul - Jun.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Jun '25 Jun '24 Jun '23 Jun '22
Revenue
22.1817.7918.3212.879.61
Revenue Growth
302.96%-2.86%42.28%34.02%-
Gross Profit
4.722.763.562.451.68
Operating Income
-6.87-4.96-0.450.25-0.12
Net Income
-3.69-5.25-0.230.98-0
Earnings Per Share
-0.19-0.69-0.040.16-0.00
EPS Growth
-----

Revenue by Segment

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Jun '25 Jun '24 Jun '23 Jun '22
Pharmaceutical Distribution (china)
7.162.76---
Cross-border Freight Solutions (u.s.)
-15.03---
Transportation - Air Freight
--18.3212.879.61
Total
22.1817.7918.3212.879.61

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Jun '25 Jun '24 Jun '23 Jun '22
Cash & Investments
1.34.960.120.170.37
Total Debt
0.526.394.633.223.93
Net Cash (Debt)
0.78-1.44-4.51-3.04-3.56
Net Cash Growth
-----
Net Cash Per Share
0.04-0.19-0.75-0.51-0.59

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Jun '25 Jun '24 Jun '23 Jun '22
Operating Cash Flow
-5.08-2.66-0.050.040.31
Capital Expenditures
-0.12-0.7--0.02-0.12
Free Cash Flow
-5.19-3.36-0.050.020.19
Free Cash Flow Growth
----88.86%-

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Jun '25 Jun '24 Jun '23 Jun '22
Gross Margin
21.26%15.52%19.46%19.05%17.50%
Operating Margin
-30.96%-27.88%-2.47%1.92%-1.23%
Pretax Margin
-30.54%-27.79%-1.61%7.84%-0.03%
Profit Margin
-16.64%-29.49%-1.23%7.64%-0.03%
FCF Margin
-23.41%-18.88%-0.29%0.16%1.96%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Jun '25 Jun '24 Jun '23 Jun '22
PS Ratio
0.500.361.31--